PHOSPHATURIC MESENCHYMAL TUMOUR

PHOSPHATURIC MESENCHYMAL TUMOUR was reported 11 times

PHOSPHATURIC MESENCHYMAL TUMOUR is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Vitamin D3 Analog [EPC] 1 0.0000
1 RANK Ligand Inhibitor [EPC] 4 0.0000
2 Parathyroid Hormone Analog [EPC] 2 0.0000
3 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1 0.0000
4 Insulin Analog [EPC] 1 0.0000